Founded in 2023, PlatinumRx operates in Health Tech industry. Initially focusing on enhancing patient adherence through customised medicine packaging and reminders, the company has expanded its servic...
Funding stage:
Series A
Last funding:
02/09/2025
Total funding:
$6.79 Mn+
Revenue:
Investors
Employee count:
111
Last 90d
111
Last 90d
Web traffic:
2.27 Mn
2.27 Mn
Last 30d
Last 30d
PlatinumRx: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders11
Latest Filing Date18 June 2025- Funding Events6
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of PlatinumRx
As of 19 June 2025, PlatinumRx's equity is held by 10 shareholders, with the top three being Ashutosh Pandey, Piyush Kumar, and IQ Alpha IV.
Ashutosh Pandey holds the largest stake in PlatinumRx at 24.9% as of 19 June 2025.
As of 19 June 2025, founders collectively hold 49.7% equity in PlatinumRx.
As of 19 June 2025, investors collectively hold 42.9% equity in PlatinumRx.
PlatinumRx's ESOP pool stands at 7.3% of total equity as of 19 June 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links